Apyx Medical Analyst Ratings
Apyx Medical Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/10/2023 | 184.07% | Stephens & Co. | $8 → $5 | Maintains | Overweight |
| 08/11/2023 | 155.67% | Piper Sandler | $4 → $4.5 | Maintains | Overweight |
| 07/14/2023 | 354.52% | Stephens & Co. | → $8 | Initiates Coverage On | → Overweight |
| 06/15/2023 | 411.33% | Lake Street | $6 → $9 | Maintains | Buy |
| 05/24/2023 | — | JMP Securities | Reiterates | → Market Perform | |
| 05/12/2023 | 240.89% | Lake Street | $5 → $6 | Maintains | Buy |
| 12/08/2022 | 184.07% | Lake Street | → $5 | Assumes | → Buy |
| 08/12/2022 | 581.78% | Piper Sandler | $6 → $12 | Maintains | Overweight |
| 07/19/2022 | 865.85% | Lake Street | $14 → $17 | Maintains | Buy |
| 05/20/2022 | 581.78% | Lake Street | → $12 | Initiates Coverage On | → Buy |
| 08/13/2021 | 695.41% | JMP Securities | $12 → $14 | Maintains | Market Outperform |
| 05/12/2020 | 184.07% | JMP Securities | $7 → $5 | Maintains | Market Outperform |
| 11/12/2019 | 468.15% | Piper Sandler | $8 → $10 | Maintains | Overweight |
| 04/02/2019 | 354.52% | JMP Securities | $12 → $8 | Maintains | Market Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 11/10/2023 | 184.07% | Stephens & Co. | 8 美元 → 5 美元 | 维护 | 超重 |
| 08/11/2023 | 155.67% | 派珀·桑德勒 | 4 美元 → 4.5 美元 | 维护 | 超重 |
| 07/14/2023 | 354.52% | Stephens & Co. | → 8 美元 | 启动覆盖范围开启 | → 超重 |
| 06/15/2023 | 411.33% | 湖街 | 6 美元 → 9 美元 | 维护 | 买 |
| 05/24/2023 | — | JMP 证券 | 重申 | → 市场表现 | |
| 05/12/2023 | 240.89% | 湖街 | 5 美元 → 6 美元 | 维护 | 买 |
| 2022 年 8 月 12 日 | 184.07% | 湖街 | → 5 美元 | 假设 | → 购买 |
| 2022 年 12 月 8 日 | 581.78% | 派珀·桑德勒 | 6 美元 → 12 美元 | 维护 | 超重 |
| 2022 年 7 月 19 日 | 865.85% | 湖街 | 14 美元 → 17 美元 | 维护 | 买 |
| 05/20/2022 | 581.78% | 湖街 | → 12 美元 | 启动覆盖范围开启 | → 购买 |
| 08/13/2021 | 695.41% | JMP 证券 | 12 美元 → 14 美元 | 维护 | 市场表现跑赢大盘 |
| 05/12/2020 | 184.07% | JMP 证券 | 7 美元 → 5 美元 | 维护 | 市场表现跑赢大盘 |
| 2019 年 12 月 11 日 | 468.15% | 派珀·桑德勒 | 8 美元 → 10 美元 | 维护 | 超重 |
| 04/02/2019 | 354.52% | JMP 证券 | 12 美元 → 8 美元 | 维护 | 市场表现跑赢大盘 |
What is the target price for Apyx Medical (APYX)?
Apyx Medical（APYX）的目标价格是多少？
The latest price target for Apyx Medical (NASDAQ: APYX) was reported by Stephens & Co. on November 10, 2023. The analyst firm set a price target for $5.00 expecting APYX to rise to within 12 months (a possible 184.07% upside). 7 analyst firms have reported ratings in the last year.
斯蒂芬斯公司于2023年11月10日公布了Apyx Medical（纳斯达克股票代码：APYX）的最新目标股价。该分析公司将目标股价定为5.00美元，预计APYX将在12个月内升至12个月内（可能上涨184.07％）。去年有7家分析公司公布了评级。
What is the most recent analyst rating for Apyx Medical (APYX)?
分析师对Apyx Medical（APYX）的最新评级是多少？
The latest analyst rating for Apyx Medical (NASDAQ: APYX) was provided by Stephens & Co., and Apyx Medical maintained their overweight rating.
Stephens & Co. 对Apyx Medical（纳斯达克股票代码：APYX）的最新分析师评级由Stephens & Co. 提供，Apyx Medical维持增持评级。
When is the next analyst rating going to be posted or updated for Apyx Medical (APYX)?
Apyx Medical（APYX）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Apyx Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Apyx Medical was filed on November 10, 2023 so you should expect the next rating to be made available sometime around November 10, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Apyx Medical的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Apyx Medical的最新评级是在2023年11月10日公布的，因此您应该预计下一个评级将在2024年11月10日左右公布。
Is the Analyst Rating Apyx Medical (APYX) correct?
分析师对Apyx Medical（APYX）的评级正确吗？
While ratings are subjective and will change, the latest Apyx Medical (APYX) rating was a maintained with a price target of $8.00 to $5.00. The current price Apyx Medical (APYX) is trading at is $1.76, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的Apyx Medical（APYX）评级保持不变，目标股价为8.00美元至5.00美元。Apyx Medical（APYX）目前的交易价格为1.76美元，超出了分析师的预期区间。